ew this as an incremental and potentially significant risk. On the other hand, VRX has a number of new products that have either recently launched (Siliq, Vyzulta, etc.) or could potentially launch upon approval (Luminesse, which has a PDUFA date of 12/27/17, and IDP-118, which has a PDUFA date of 6/